GenAssist, Inc.
GenAssist Inc. develops innovative biomaterials aimed at regenerating muscle tissue, particularly for patients suffering from traumatic muscle injuries. Their flagship technology, MyoMatrix™, is designed to support and heal muscle wounds caused by high-impact trauma, disease, and other injuries, with the potential to significantly improve recovery outcomes and reduce disability.
Industries
Nr. of Employees
small (1-50)
Products
Implantable porous scaffold for skeletal muscle reinforcement
A porous, sponge-like biomimetic scaffold designed to provide mechanical support to injured muscle tissue and to be replaced by endogenous muscle over several weeks.
Thermoresponsive injectable gel for muscle reinforcement
An injectable gel formulation based on the same biomimetic extracellular matrix proteins, provided in a pre-loaded syringe and designed to remain gelled at body temperature to support muscle tissue with a minimally invasive procedure.
Implantable porous scaffold for skeletal muscle reinforcement
A porous, sponge-like biomimetic scaffold designed to provide mechanical support to injured muscle tissue and to be replaced by endogenous muscle over several weeks.
Thermoresponsive injectable gel for muscle reinforcement
An injectable gel formulation based on the same biomimetic extracellular matrix proteins, provided in a pre-loaded syringe and designed to remain gelled at body temperature to support muscle tissue with a minimally invasive procedure.
Expertise Areas
- Muscle tissue engineering
- Biomaterials formulation and delivery
- Preclinical model development and validation
- Translational medicine and clinical indication development
Key Technologies
- Extracellular matrix-based biomaterials
- Porous sponge-like implantable scaffolds
- Thermoresponsive injectable hydrogels
- Syringe-based minimally invasive delivery